US 9642805
Aptamer-loaded, biocompatible nanoconstructs for nuclear-targeted cancer therapy
granted A61KA61K31/711A61K41/0042
Quick answer
US patent 9642805 (Aptamer-loaded, biocompatible nanoconstructs for nuclear-targeted cancer therapy) held by Northwestern University expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Northwestern University
- Grant date
- Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/711, A61K41/0042, A61K47/6923, A61K9/14